Premium
Severe COVID ‐19 and interleukin‐6 receptor antagonist tocilizumab: Some notes of concern
Author(s) -
Akinosoglou Karolina,
Gogos Charalambos
Publication year - 2020
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13939
Subject(s) - tocilizumab , medicine , covid-19 , interleukin 1 receptor antagonist , receptor antagonist , antagonist , receptor , interleukin 6 , virology , interleukin , betacoronavirus , immunology , cytokine , outbreak , rheumatoid arthritis , disease , infectious disease (medical specialty)
See related reply